NYSE MKT LLC · IBO
+6.83% · +$0.0307 · Vol 22.8K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Impact Biomedical Inc

Impact Biomedical Inc

Pharmaceuticals
$0.4800
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
IBO
Impact Biomedical Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

43/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IBO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IBO catalysts
About Impact Biomedical Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
8
Country
US

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4383
Day high
$0.4800
Day low
$0.4383
Previous close
$0.4493
52W high
$0.7800
-38.46% from high
52W low
$0.4008
21% of range
Market cap
$51.8M
EPS
$-1.3300
Beta
-0.69
Shares out
107.8M
Volume
22.8K
0.73× rel vol
Avg volume
31.1K
VWAP
$0.4598
Price history computed in-house
1W
+0.54%
1M
+9.09%
3M
-6.25%
1Y
-19.85%
YTD
-4.95%
SMA 50 $0.4680 · above
SMA 200 $0.5167 · below
52W position 21%

IBO overview

Veridion Score
43
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IBO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IBO Form 4 filings
Public disclosures

Congress activity in IBO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IBO in the cached public ledger.

Federal contracts

IBO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IBO in this window.
Lobbying spend

IBO lobbying filings, year to date.

Registered lobbying filings matched to Impact Biomedical Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IBO in this window.
Loading news for IBO
Analyst ratings
Sovereign unlock shows live analyst consensus for IBO.
Options
Sovereign unlock shows live options positioning for IBO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.